ZA200203455B - 3-methylene steroid derivatives for the treatment of autoimmune diseases. - Google Patents

3-methylene steroid derivatives for the treatment of autoimmune diseases.

Info

Publication number
ZA200203455B
ZA200203455B ZA200203455A ZA200203455A ZA200203455B ZA 200203455 B ZA200203455 B ZA 200203455B ZA 200203455 A ZA200203455 A ZA 200203455A ZA 200203455 A ZA200203455 A ZA 200203455A ZA 200203455 B ZA200203455 B ZA 200203455B
Authority
ZA
South Africa
Prior art keywords
treatment
autoimmune diseases
steroid derivatives
methylene steroid
methylene
Prior art date
Application number
ZA200203455A
Other languages
English (en)
Inventor
Ralf Plate
Wilhelmina Maria Bagchus
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA200203455B publication Critical patent/ZA200203455B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200203455A 1999-11-29 2002-04-30 3-methylene steroid derivatives for the treatment of autoimmune diseases. ZA200203455B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204000 1999-11-29

Publications (1)

Publication Number Publication Date
ZA200203455B true ZA200203455B (en) 2004-04-28

Family

ID=8240918

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203455A ZA200203455B (en) 1999-11-29 2002-04-30 3-methylene steroid derivatives for the treatment of autoimmune diseases.

Country Status (30)

Country Link
US (2) US6579864B1 (xx)
EP (1) EP1240179B1 (xx)
JP (1) JP2003517472A (xx)
KR (1) KR100720326B1 (xx)
CN (1) CN1254479C (xx)
AR (1) AR033503A1 (xx)
AT (1) ATE319732T1 (xx)
AU (1) AU778773B2 (xx)
BR (1) BR0015950A (xx)
CA (1) CA2391096A1 (xx)
CO (1) CO5251432A1 (xx)
CY (1) CY1106088T1 (xx)
CZ (1) CZ20021837A3 (xx)
DE (1) DE60026608T2 (xx)
DK (1) DK1240179T3 (xx)
ES (1) ES2259624T3 (xx)
HK (1) HK1047595B (xx)
HU (1) HUP0203596A3 (xx)
IL (2) IL149412A0 (xx)
MX (1) MXPA02005334A (xx)
NO (1) NO323136B1 (xx)
NZ (1) NZ518756A (xx)
PE (1) PE20010980A1 (xx)
PL (1) PL355968A1 (xx)
PT (1) PT1240179E (xx)
RU (1) RU2248358C2 (xx)
SK (1) SK285398B6 (xx)
TW (1) TWI265167B (xx)
WO (1) WO2001040253A2 (xx)
ZA (1) ZA200203455B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
EP1734998A2 (en) 2004-04-14 2006-12-27 Genentech, Inc. Compositions and methods comprising an egfl7 antagonist for modulating vascular development

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1085035A (en) * 1913-05-01 1914-01-20 George H Greimann Ditch-digging machine.
US1171221A (en) * 1915-12-13 1916-02-08 Charles Ephriam Marion Combination-tool.
US3213117A (en) * 1963-07-03 1965-10-19 Syntex Corp Process for preparation of delta1(10)-5alpha-estren-17beta-ol-2-one and derivatives thereof
BE654772A (xx) * 1963-10-23
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
DE3560449D1 (en) 1984-03-29 1987-09-17 Ciba Geigy Ag Substituted 1-propanoles, process for their production, chloroformic-acid esters ad their use
GB8513723D0 (en) 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives

Also Published As

Publication number Publication date
AR033503A1 (es) 2003-12-26
AU2508701A (en) 2001-06-12
SK7272002A3 (en) 2002-09-10
HUP0203596A3 (en) 2003-12-29
PL355968A1 (en) 2004-05-31
EP1240179A2 (en) 2002-09-18
PT1240179E (pt) 2006-05-31
US20040043972A1 (en) 2004-03-04
DE60026608D1 (de) 2006-05-04
IL149412A0 (en) 2002-11-10
KR20030024656A (ko) 2003-03-26
SK285398B6 (sk) 2007-01-04
NO20022521L (no) 2002-05-28
CY1106088T1 (el) 2011-06-08
NZ518756A (en) 2004-05-28
WO2001040253A2 (en) 2001-06-07
BR0015950A (pt) 2002-11-12
HK1047595B (zh) 2006-05-04
TWI265167B (en) 2006-11-01
HK1047595A1 (en) 2003-02-28
WO2001040253A3 (en) 2002-05-02
CN1402734A (zh) 2003-03-12
JP2003517472A (ja) 2003-05-27
US6579864B1 (en) 2003-06-17
NO20022521D0 (no) 2002-05-28
CO5251432A1 (es) 2003-02-28
CA2391096A1 (en) 2001-06-07
PE20010980A1 (es) 2001-10-02
CN1254479C (zh) 2006-05-03
MXPA02005334A (es) 2003-04-10
IL149412A (en) 2007-07-24
KR100720326B1 (ko) 2007-05-22
DE60026608T2 (de) 2006-12-28
HUP0203596A2 (hu) 2003-02-28
DK1240179T3 (da) 2006-07-03
ES2259624T3 (es) 2006-10-16
EP1240179B1 (en) 2006-03-08
CZ20021837A3 (cs) 2002-08-14
AU778773B2 (en) 2004-12-23
NO323136B1 (no) 2007-01-08
RU2248358C2 (ru) 2005-03-20
ATE319732T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
ZA200203581B (en) Bicyclic imidazo-3-yl-amine derivatives.
AU7842500A (en) System for orthopedic treatment
MXPA02002898A (es) Pirazolopirimidinas como agentes terapeuticos.
AU6910600A (en) Methods for the treatment of mental disorders
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
ZA200003236B (en) Combination therapy for the treatment of migraine.
AU4364400A (en) Azaindole derivatives for the treatment of depression
HUP0104963A3 (en) Compositions for the treatment of skin diseases
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
GB9927757D0 (en) Treatment of autoimmune diseases
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
ZA200203455B (en) 3-methylene steroid derivatives for the treatment of autoimmune diseases.
AU2080201A (en) Treatment of addiction disorders
HUP0001891A2 (en) Medicament for the treatment of migraine
ZA200003235B (en) Combination therapy for the treatment of migraine.
ZA200203166B (en) Treatment of cancer.
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
AU3501100A (en) Synergistic combination for treatment of viral-mediated diseases
AU1405001A (en) Treatment of diseases
AU6896300A (en) Vaccines for the treatment of autoimmune disease
MXPA03004454A (es) Derivados de imidazolona para el tratamiento de enfermedades virales.
AU6234000A (en) Methods for treating autoimmune diseases
EP1225223A4 (en) MEDICINAL PRODUCT WITH P21 CIP1 AGAINST RHEUMA